Dataset Paper

Alterations of Hormone-Sensitive Adenylyl Cyclase System in the Tissues of Rats with Long-Term Streptozotocin Diabetes and the Influence of Intranasal Insulin

Table 4

The stimulating effects of hormones on AC activity in (a) the heart, (b) brain, and (c) testes of diabetic and control rats with and without therapy by I-I. C: control animals; CI: control animals treated with intranasal insulin (I-I); D: diabetic animals with 210-day streptozotocin-induced diabetes mellitus of the type 1 (T1DM); DI: diabetic animals treated with I-I. Isoproterenol, noradrenaline, serotonin, EMD-386088, and dopamine were taken at 10−5 M, PACAP-38 at 10−7 M, and hCG at 10−8 M. Values are the weighted mean ± weighted standard deviation of three individual experiments, each performed in triplicate.
(a) In picomole (pmol) of cAMP/min per milligram (mg) of membrane protein

Groups of RatsIsoproterenolNoradrenaline

Group C (n = 8)65.0 ± 2.7
(C-D,
P = 0.0004;
C-CI, P = 0.1348)
47.2 ± 1.1
(C-D,
P = 10−8;
C-CI,
P = 0.4434)
Average of the first series 73.753.6
Average of the second series 54.9 48.1
Average of the third series66.646.0
Group CI (n = 7)60.3 ± 0.9
(CI-DI, P = 0.2191)
52.7 ± 1.9
(CI-DI, P = 0.1188)
Average of the first series61.642.6
Average of the second series61.156.7
Average of the third series57.355.0
Group D (n = 8)47.0 ± 1.8
(D-DI, P = 0.0032)
29.5 ± 1.6
(D-DI, P = 0.0025)
Average of the first series43.930.3
Average of the second series44.432.3
Average of the third series55.225.8
Group DI (n = 7)56.2 ± 1.737.9 ± 2.3
Average of the first series53.831.9
Average of the second series56.151.4
Average of the third series62.049.8

(b) In picomole (pmol) of cAMP/min per milligram (mg) of membrane protein

Groups of RatsIsoproterenolSerotoninEMD-386088DopaminePACAP-38

Group C (n = 8)42.6 ± 1.1
(C-D, P = 10−9;
C-CI,
P = 0.0374)
81.3 ± 2.2
(C-D, P = 0.0066;
C-CI, P = 0.7467)
28.3 ± 1.8
(C-D, P = 0.0004;
C-CI, P = 0.3930)
52.2 ± 1.0
(C-D, P = 0.1771;
C-CI, P = 0.0050)
34.1 ± 0.3
(C-D, P = 10−8;
C-CI, P = 0.0382)
Average of the first series41.690.029.551.833.7
Average of the second series42.681.127.350.036.3
Average of the third series45.875.933.555.136.1
Group CI (n = 7)40.3 ± 1.2
(CI-DI, P = 0.0226)
81.8 ± 2.1
(CI-DI, P = 0.0107)
34.2 ± 2.0
(CI-DI, P = 0.2647)
47.7 ± 1.2
(CI-DI, P = 0.4680)
37.8 ± 1.2
(CI-DI, P = 0.2633)
Average of the first series40.683.230.046.640.6
Average of the second series42.892.228.145.135.3
Average of the third series37.375.139.051.2 38.7
Group D (n = 8)28.0 ± 0.8
(D-DI, P = 0.0031)
67,2 ± 4.0
(D-DI, P = 0.1032)
21.4 ± 1.2
(D-DI, P = 0.00065)
44.4 ± 5.1
(D-DI, P = 0.8898)
22.3 ± 0.7
(D-DI, P = 10−5)
Average of the first series26.851.520.556.822.2
Average of the second series29.472.619.432.725.0
Average of the third series30.075.323.447.619.2
Group DI (n = 7)33.9 ± 1.774.8 ± 1.329.5 ± 2.046.2 ± 1.737.9 ± 2.0
Average of the first series33.975.925.450.234.7
Average of the second series40.576.729.643.332.8
Average of the third series31.770.833.245.640.2

(c) In picomole (pmol) of cAMP/min per milligram (mg) of membrane protein

Groups of RatshCGPACAP-38

Group C (n = 8)105 ± 4
(C-D, P = 10−7;
C-CI, P = 0.0270)
53 ± 3
(C-D, P = 10−5;
C-CI, P = 0.4720)
Average of the first series12744
Average of the second series10552
Average of the third series9558
Group CI (n = 7)89 ± 5
(CI-DI, P = 0.0039)
50 ± 2
(CI-DI, P = 0.0007)
Average of the first series11050
Average of the second series7645
Average of the third series8469
Group D (n = 8)40 ± 3
(D-DI, P = 10−7)
29 ± 2
(D-DI, P = 0.1024)
Average of the first series4025
Average of the second series4735
Average of the third series3630
Group DI (n = 7)67 ± 234 ± 2
Average of the first series6629
Average of the second series6336
Average of the third series7140